Literature DB >> 9291129

P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain.

E Beaulieu1, M Demeule, L Ghitescu, R Béliveau.   

Abstract

Luminal membranes of the vascular endothelium were isolated from brain, heart and lungs by modification of their density. The presence of P-glycoprotein (P-gp) was detected by Western blotting in luminal membranes from the endothelium of the three tissues. Strong enrichment in brain capillary luminal membranes, compared with brain capillaries (17-fold) and whole membranes (400-500-fold), indicates that P-gp is mainly located on the luminal side of the brain endothelium. Western blotting was also performed with antibodies directed against GLUT1, glial fibrillary acidic protein, adaptin, IP3R-3, integrins alphav and collagen IV as controls to determine whether the preparations were contaminated by other membranes. Strong enrichment of GLUT1 in brain capillary luminal membranes (9.9-fold) showed that the preparation consisted mainly of endothelial cell plasma membranes. Poor enrichment of glial fibrillary acidic protein (1.4-fold) and adaptin (2.4-fold) and a decreased level of IP3R-3, integrins alphav and collagen IV excludes the possibility of major contamination by astrocytes or internal and anti-luminal membranes. High levels of P-gp in the luminal membranes of brain capillary endothelial cells suggests that it may play an important role in limiting the access of anti-cancer drugs to the brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291129      PMCID: PMC1218702          DOI: 10.1042/bj3260539

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

Review 1.  P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.

Authors:  D Nielsen; T Skovsgaard
Journal:  Biochim Biophys Acta       Date:  1992-07-07

Review 2.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

3.  Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.

Authors:  J J Smit; A H Schinkel; R P Oude Elferink; A K Groen; E Wagenaar; L van Deemter; C A Mol; R Ottenhoff; N M van der Lugt; M A van Roon
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

4.  High levels of P-glycoprotein detected in isolated brain capillaries.

Authors:  L Jetté; B Têtu; R Béliveau
Journal:  Biochim Biophys Acta       Date:  1993-08-15

5.  Detection of P-glycoprotein with four monoclonal antibodies in normal and tumor tissues.

Authors:  Z P Pavelic; J Reising; L Pavelic; D J Kelley; P J Stambrook; J L Gluckman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1993-07

6.  Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells.

Authors:  C A Doige; F J Sharom
Journal:  Biochim Biophys Acta       Date:  1992-08-24

7.  P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells.

Authors:  A Tsuji; T Terasaki; Y Takabatake; Y Tenda; I Tamai; T Yamashima; S Moritani; T Tsuruo; J Yamashita
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

8.  In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptozotocin-diabetic rats.

Authors:  H Kainulainen; M Breiner; A Schürmann; A Marttinen; A Virjo; H G Joost
Journal:  Biochim Biophys Acta       Date:  1994-02-22

9.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.

Authors:  A H Schinkel; J J Smit; O van Tellingen; J H Beijnen; E Wagenaar; L van Deemter; C A Mol; M A van der Valk; E C Robanus-Maandag; H P te Riele
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

10.  P-glycoprotein expression in brain tumors.

Authors:  J W Henson; C Cordon-Cardo; J B Posner
Journal:  J Neurooncol       Date:  1992-09       Impact factor: 4.130

View more
  66 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice.

Authors:  Meysam Abbasi; Hamidreza Montazeri Aliabadi; Elaine H Moase; Afsaneh Lavasanifar; Kamaljit Kaur; Raymond Lai; Charles Doillon; Hasan Uludağ
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

Review 3.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

Review 4.  P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

Authors:  Sanjay U C Sankatsing; Jos H Beijnen; Alfred H Schinkel; Joep M A Lange; Jan M Prins
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

Review 5.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

Review 6.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 7.  Apicobasal polarity of brain endothelial cells.

Authors:  Thomas Worzfeld; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-06       Impact factor: 6.200

Review 8.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

Review 9.  Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?

Authors:  Qian Zhang; Yunjiang Feng; Derek Kennedy
Journal:  Cell Mol Life Sci       Date:  2016-09-12       Impact factor: 9.261

10.  Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells.

Authors:  E V Batrakova; H Y Han; D W Miller; A V Kabanov
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.